Martin Fan
Stock Analyst at Wedbush
(4.87)
# 64
Out of 5,150 analysts
19
Total ratings
77.78%
Success rate
60.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Martin Fan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZURA Zura Bio | Initiates: Outperform | $15 | $6.49 | +131.12% | 1 | Feb 9, 2026 | |
| ORKA Oruka Therapeutics | Maintains: Outperform | $42 → $45 | $32.84 | +37.03% | 2 | Jan 13, 2026 | |
| ZBIO Zenas BioPharma | Reiterates: Outperform | $45 | $25.18 | +78.71% | 3 | Dec 22, 2025 | |
| VOR Vor Biopharma | Assumes: Neutral | $9 | $14.95 | -39.80% | 1 | Nov 25, 2025 | |
| IMA ImageneBio | Assumes: Underperform | $2 | $6.13 | -67.37% | 1 | Nov 25, 2025 | |
| ANAB AnaptysBio | Reiterates: Outperform | $50 | $52.83 | -5.36% | 5 | Nov 24, 2025 | |
| SANA Sana Biotechnology | Maintains: Outperform | $5 → $6 | $3.93 | +52.67% | 2 | Nov 7, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Outperform | $18 → $23 | $5.47 | +320.48% | 2 | Oct 17, 2025 | |
| RNAC Cartesian Therapeutics | Initiates: Outperform | $38 | $7.48 | +408.02% | 1 | Jul 9, 2025 | |
| ACRS Aclaris Therapeutics | Initiates: Outperform | $8 | $3.04 | +163.16% | 1 | May 28, 2025 |
Zura Bio
Feb 9, 2026
Initiates: Outperform
Price Target: $15
Current: $6.49
Upside: +131.12%
Oruka Therapeutics
Jan 13, 2026
Maintains: Outperform
Price Target: $42 → $45
Current: $32.84
Upside: +37.03%
Zenas BioPharma
Dec 22, 2025
Reiterates: Outperform
Price Target: $45
Current: $25.18
Upside: +78.71%
Vor Biopharma
Nov 25, 2025
Assumes: Neutral
Price Target: $9
Current: $14.95
Upside: -39.80%
ImageneBio
Nov 25, 2025
Assumes: Underperform
Price Target: $2
Current: $6.13
Upside: -67.37%
AnaptysBio
Nov 24, 2025
Reiterates: Outperform
Price Target: $50
Current: $52.83
Upside: -5.36%
Sana Biotechnology
Nov 7, 2025
Maintains: Outperform
Price Target: $5 → $6
Current: $3.93
Upside: +52.67%
Artiva Biotherapeutics
Oct 17, 2025
Maintains: Outperform
Price Target: $18 → $23
Current: $5.47
Upside: +320.48%
Cartesian Therapeutics
Jul 9, 2025
Initiates: Outperform
Price Target: $38
Current: $7.48
Upside: +408.02%
Aclaris Therapeutics
May 28, 2025
Initiates: Outperform
Price Target: $8
Current: $3.04
Upside: +163.16%